Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms

Bone(2023)10.1016/j.bone.2023.116805Source: DataRank Database

Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms is a research paper published in Bone (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 3.17)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Rosario Saldivar,Ratan Kumar ORCID,Corinne E. Metzger ORCID,Andrea M. Jacobson ORCID,Matthew R. Allen ORCID

Live enrichment

PubMed:37196853 PMC:PMC10330631 OpenAlex:https://openalex.org/W4376649020

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: T32DK120524-02

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: R01AR072609

National Science Foundation

Grant: LEAP-HI 1952993

NIDDK NIH HHS

Grant: T32 DK120524

NIDDK NIH HHS

Grant: L30 DK130133

BLRD VA

Grant: IK6 BX006479

BLRD VA

Grant: I01 BX003025

National Institutes of Health

FWCI

3.17

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10330631/pdf/nihms-1904146.pdf

publisherhttps://api.elsevier.com/content/article/PII:S8756328223001382?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S8756328223001382?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10330631

Fields of Study

Bone health and osteoporosis researchBone Metabolism and DiseasesBone health and treatmentsAnimalsMaleMiceBone Density Conservation AgentsCalcitoninFractures, BoneMice, Inbred C57BLRaloxifene HydrochlorideWater

MeSH Terms

AnimalsCalcitoninMaleMice, Inbred C57BLWaterRaloxifene HydrochlorideBone Density Conservation AgentsFractures, BoneMice

Keywords

RaloxifeneEx vivoOsteoporosisMedicineKidney diseaseIn vivoCortical boneEndocrinologyCalcitoninBone mineralInternal medicineUrologyChemistryPathologyBiologyEstrogen receptorNuclear magnetic resonanceSalmon calcitoninMaterial PropertiesBone Hydration

Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms

FAIR Checklist

Authors (7)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)